0001144204-18-061812.txt : 20181128 0001144204-18-061812.hdr.sgml : 20181128 20181127203113 ACCESSION NUMBER: 0001144204-18-061812 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181128 DATE AS OF CHANGE: 20181127 EFFECTIVENESS DATE: 20181128 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Akelos, Inc. CENTRAL INDEX KEY: 0001760186 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-326660 FILM NUMBER: 181204029 BUSINESS ADDRESS: STREET 1: 40 PARK AVENUE, SUITE 6 CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 212-953-1544 MAIL ADDRESS: STREET 1: 40 PARK AVENUE, SUITE 6 CITY: NEW YORK STATE: NY ZIP: 10016 D 1 primary_doc.xml X0708 D LIVE 0001760186 Akelos, Inc. 40 PARK AVE SUITE 6 NEW YORK NY NEW YORK 10016 212-953-1544 DELAWARE None None Corporation true 2018 Steven Fox c/o Akelos, Inc. 40 Park Ave Suite 6 New York NY NEW YORK 10016 Executive Officer Director Biotechnology Decline to Disclose 06b false 2018-10-23 false true false 0 295000 295000 0 false 12 0 0 29176 Represents the repayment of non-interest bearing working capital advances. false Akelos, Inc. /s/ Steven Fox Steven Fox President 2018-11-27